Support

Story preview

Teva Pharmaceutical Industries (NYSE:TEVA) Given New $47.00 Price Target at Barclays

MarketBeat

About this story

Published
Oct 15, 2026, 3:17 PM UTC

Topics in this story

#teva#pharmaceutical#industries#nyse#given

Continue reading on the publisher site for the full article.

Read on publisher →MarketBeat

News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee

At a glance

Coverage

Tone

Who else is covering this

Where in the world it’s covered

Coverage over time

Tone of the coverage

About the publisher

Related topics

Teva Pharmaceutical Industries (NYSE:TEVA) Given New $47.00 Price Target at Barclays · News Atlas